The final analysis has shown that eNOS-Intron 4a/b VNTR polymorphism was related to an increased risk of urogenital neoplasms in recessive model (BB vs. BA + AA: OR = 2.725, 95%CI = 1.608–4.619, PA = 1.970E-04). Here, NOS3 is linked to urogenital neoplasm.